Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...
Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...
Wegovy and Ozempic remain on the FDA's shortages list, despite strenuous efforts by Novo Nordisk to ramp up its production capacity for semaglutide. The Danish drugmaker has asked the FDA to move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback